About this trial

This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.

Eligibility criteria

Qualifiers

Documented diagnosis of psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.

Age 12 years or older at the first recorded visit.

Eligible for or treated with systemic therapies.

At least one documented visit during January 2016 to December 2025.

Disqualifiers

Opt-out exercised.

Medical records with insufficient data.

Trial design

Treatments tested in this trial

  • Conventional Systemic Therapies
  • Biologic Therapies

Treatment groups

20,000 Participants
are divided into 5 treatment groups

Locations

1
IRCCS Istituto Clinico Humanitas - Dermatology Unit20089, RozzanoLombardy, Italy

Sponsors and collaborators

Fondazione ISIDE

Lead sponsor